Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Actavis Plc (ACT)

2015-03-05@20:39:01 ET
Actavis, Inc.Corporate Event Announcement Notice (WSH)

2015-03-04@17:45:00 ET
(PRN)

2015-03-03@19:30:00 ET
Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan (PRN)

2015-03-03@18:39:48 ET
M and A Navigator: Deal pipeline -3 March (MTN)

2015-03-03@17:58:50 ET
Deal snapshot: ACTAVIS CLOSES SHARE OFFERING IN CONNECTION WITH ALLERGAN ACQUISITION (MTN)

2015-03-03@16:57:40 ET
Actavis Closes Share Offerings in Connection with USD 66bn Allergan Acquisition (MTN)

2015-03-03@06:00:39 ET
Actavis to issue senior notes in public offering in connection with pending acquisition of Allergan (MTO)

2015-03-02@17:00:00 ET
Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan (PRN)

2015-03-02@08:30:00 ET
Actavis Receives Approval from the European Commission for XYDALBA(TM) (dalbavancin) (PRN)

2015-03-02@07:57:00 ET
Actavis Announces Proposed Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan (PRN)

2015-02-27@08:00:00 ET
Actavis and Medicines360 Announce FDA Approval of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years (PRN)

2015-02-26@09:30:00 ET
Where Opportunity is Found: Special Research on LendingTree, Bank of America, Actavis, Royal Bank of Canada, and Dycom (PRN)

2015-02-26@04:41:42 ET
Actavis wins US FDA approval for AVYCAZ for treating complicated intra-abdominal and urinary tract infections (MTO)

2015-02-26@04:41:42 ET
Actavis wins US FDA approval for AVYCAZ for treating complicated intra-abdominal and urinary tract infections (MTO)

2015-02-25@17:21:00 ET
Actavis Receives U.S. FDA Approval for AVYCAZ(TM) (CEFTAZIDIME-AVIBACTAM) (PRN)

2015-02-25@08:00:00 ET
Actavis Announces Pricing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan (PRN)

2015-02-24@16:05:00 ET
(PRN)

2015-02-23@08:45:00 ET
Pharma Stocks under Review - Zoetis, Actavis, Mylan, Akorn, and VIVUS (PRN)

2015-02-23@04:07:41 ET
Actavis wins final US FDA approval for generic Subutex for treating opioid dependence (MTO)

2015-02-20@08:45:00 ET
(PRN)